Preventing RSV: Providing Older Patients with the Information They Need Series

Register

This series is designed for healthcare professionals to enhance their knowledge and awareness related to the pathophysiology, prevalence, and overall burden of Respiratory Syncytial Virus (RSV) among older adults, as well as the latest data and evidence in support of vaccines and their potential to impact prevention strategies for older adults. This series features microlearning, interactive cases, panel discussions, podcasts, and a trivia game.

Activities

Relative Risk Assessment: Impact of RSV in the Adult Population | 0.75 AAPA Category 1 CME credit
Learning Objectives
  • Summarize the disease burden of RSV in U.S. adults, with a focus on hospitalizations, comorbidities, and related health disparities
  • Assess the data for RSV vaccines to determine their potential role in prevention strategies for older adults

RSV Vaccination: Talking With Patients About Their Options | 1.0 AAPA Category 1 CME credit
Learning Objectives
  • Summarize the disease burden of RSV in U.S. adults, with a focus on hospitalizations, comorbidities, and related health disparities
  • Assess the data for RSV vaccines to determine their potential role in prevention strategies for older adults

Occurrence and Disease Course of RSV Illness in Adults | 1.0 AAPA Category 1 CME credit
Learning Objectives
  • Describe the mechanism of RSV illness in adults, as well as its overall incidence in this population
  • Summarize the disease burden of RSV illness in U.S. adults, with a focus on hospitalizations, comorbidities, and health disparities

Acknowledgment of Commercial Support

This activity is supported by an educational grant from GSK.


AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.

Register